John Ferris (l) and Cadmus C. Rich, MD, were elected to Prevent Blindness’ National Board of Directors.

CHICAGO—Prevent Blindness announced that John Ferris, MBA, vice president and general manager of Vision Care at Bausch + Lomb and Cadmus C. Rich, MD, MBA, CPE, senior vice president and chief medical officer of Aura Biosciences, have been elected to the Prevent Blindness board of directors. The vote was held on Nov. 3 at the 2017 Prevent Blindness Annual Board Meeting here.

At Bausch + Lomb, John Ferris is responsible for management of the U.S. contact lens business. He was previously the vice president of marketing for the company’s eye vitamins business, managing the company’s PreserVision and Ocuvite brands. He first began working directly with Prevent Blindness in 2015 as part of the #WhyEyeFight program, an annual collaboration between Bausch + Lomb and Prevent Blindness to raise awareness of age-related macular degeneration (AMD).

As the chief medical officer and an ophthalmologist, Dr. Cadmus C. Rich is responsible for medical, clinical and therapeutic strategy and execution for Aura Biosciences. Dr. Rich was previously the vice president of Medical Affairs and Business Development at Inotek Pharmaceuticals, and at Alcon Laboratories, Inc., he served as the therapeutic unit head-Intraocular Lenses, and was the head of Clinical Trials Management-Pharmaceuticals.

“We enthusiastically welcome Mr. Ferris and Dr. Rich to our Board of Directors, and we look forward to their unique insights and expertise in helping us continue our sight-saving mission,” stated Hugh R. Parry, president and CEO of Prevent Blindness.